# Protein Timing Muscle Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/protein-timing-muscle-randomized-trial-evidence-review
Category: evidence-review
Summary: Protein Timing Muscle Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are 
Last reviewed: 2026-06-08
Reviewed by: Migaku Evidence Review
# Protein Timing Muscle Randomized Trial: What the Evidence Says

## Quick Answer

Protein Timing Muscle Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 randomized trial, 1 preclinical study.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Effects of Green Tea–Intake Timing on Glucose and Lipid Metabolism in Older Adults: An 8‐Week Randomized Controlled Trial | randomized trial | 2 | 2026-04-07 | 10.1155/jnme/2301278 |
| To Reenvision and Redefine: Considering the Role of Lifestyle Interventions in the New Era of Second-Generation Obesity Management Medications | preclinical study | 4 | 2026-05-25 | 10.1007/s11883-026-01426-y |

## What The Sources Report

- The risk of NCDs such as diabetes and cardiovascular disease increases with aging due to a progressive decline in metabolic function. [Fuke Saeka (2026); evidence level 2]
- The World Health Organization identifies elevated blood glucose level and abnormal lipid profiles as key risk factors for NCDs. [Fuke Saeka (2026); evidence level 2]
- For example, patients are typically advised to follow a reduced-calorie diet, engage in 200-300 min of physical activity per week, and participate in behavioral strategies that support weight loss, such as monitoring food intake and physical activity habits, problem-solving, and setting diet and physical activity goals. [Peary Alexandra (2026); evidence level 4]
- Physical activity and dietary interventions can independently and jointly improve cardiometabolic risk factors central to atherosclerosis through both weight-dependent and weight-independent pathways. [Peary Alexandra (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For protein timing muscle randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Fuke Saeka (2026). Effects of Green Tea–Intake Timing on Glucose and Lipid Metabolism in Older Adults: An 8‐Week Randomized Controlled Trial. DOI: 10.1155/jnme/2301278. PMCID: PMC13054514. PMID: 41952965. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13054514/
- Peary Alexandra (2026). To Reenvision and Redefine: Considering the Role of Lifestyle Interventions in the New Era of Second-Generation Obesity Management Medications. DOI: 10.1007/s11883-026-01426-y. PMCID: PMC13201336. PMID: 42183911. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is .... https://pmc.ncbi.nlm.nih.gov/articles/PMC13201336/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.